Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Rizzolio

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Journal of Cellular Physiology|January 31, 2019
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effectsConcetta Russo Spena, Lucia De Stefano, Giulio Poli, et al.
Journal of Medicinal Chemistry|January 7, 2015
Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma modelIlaria Paterni, Simone Bertini, Carlotta Granchi, et al.
Journal of Cellular Physiology|December 19, 2014
Clinical predictive circulating peptides in rectal cancer patients treated with neoadjuvant chemoradiotherapySara Crotti, Maria Vittoria Enzo, Chiara Bedin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2017
Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacySamer Bayda, Mohamad Hadla, Stefano Palazzolo, et al.
Cancer Letters|November 15, 2025
Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancerGloria Saorin, Matteo Mauceri, Isabella Caligiuri, et al.
Pharmaceutics|October 27, 2019
Strategies for Delivery of siRNAs to Ovarian Cancer CellsRossella Farra, Matea Maruna, Francesca Perrone, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 11, 2018
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancerConcetta Russo Spena, Lucia De Stefano, Stefano Palazzolo, et al.
European Journal of Medicinal Chemistry|April 10, 2012
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffoldClementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, et al.
Chemical Science|September 9, 2024
Comparative study of the antiproliferative activity of heterometallic carbene gold(i)-platinum(ii) and gold(i)-palladium(ii) complexes in cancer cell linesMartin C Dietl, Melina Maag, Sophia Ber, et al.
Journal of Cellular Physiology|December 16, 2017
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer researchMartina Piccoli, Edoardo D'Angelo, Sara Crotti, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Journal of Cellular Physiology|January 31, 2019
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effectsConcetta Russo Spena, Lucia De Stefano, Giulio Poli, et al.
Journal of Medicinal Chemistry|January 7, 2015
Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma modelIlaria Paterni, Simone Bertini, Carlotta Granchi, et al.
Journal of Cellular Physiology|December 19, 2014
Clinical predictive circulating peptides in rectal cancer patients treated with neoadjuvant chemoradiotherapySara Crotti, Maria Vittoria Enzo, Chiara Bedin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2017
Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacySamer Bayda, Mohamad Hadla, Stefano Palazzolo, et al.
Cancer Letters|November 15, 2025
Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancerGloria Saorin, Matteo Mauceri, Isabella Caligiuri, et al.
Pharmaceutics|October 27, 2019
Strategies for Delivery of siRNAs to Ovarian Cancer CellsRossella Farra, Matea Maruna, Francesca Perrone, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 11, 2018
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancerConcetta Russo Spena, Lucia De Stefano, Stefano Palazzolo, et al.
European Journal of Medicinal Chemistry|April 10, 2012
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffoldClementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, et al.
Chemical Science|September 9, 2024
Comparative study of the antiproliferative activity of heterometallic carbene gold(i)-platinum(ii) and gold(i)-palladium(ii) complexes in cancer cell linesMartin C Dietl, Melina Maag, Sophia Ber, et al.
Journal of Cellular Physiology|December 16, 2017
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer researchMartina Piccoli, Edoardo D'Angelo, Sara Crotti, et al.
Pageof 16